Complete reference list (PDF 1191 KB) - Department of Health and ...
Complete reference list (PDF 1191 KB) - Department of Health and ...
Complete reference list (PDF 1191 KB) - Department of Health and ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
70. Clifford V, Crawford NW, Royle J, et al. Recurrent apnoea post immunisation: informing reimmunisation<br />
policy. Vaccine 2011;29:5681-7.<br />
71. Flatz-Jequier A, Posfay-Barbe KM, Pfister RE, Siegrist CA. Recurrence <strong>of</strong> cardiorespiratory<br />
events following repeat DTaP-based combined immunization in very low birth weight premature<br />
infants. Journal <strong>of</strong> Pediatrics 2008;153:429-31.<br />
72. Vennemann MM, Butterfass-Bahloul T, Jorch G, et al. Sudden infant death syndrome: no<br />
increased risk after immunisation. Vaccine 2007;25:336-40.<br />
73. Jonville-Béra AP, Autret-Leca E, Barbeillon F, Paris-Llado J, French Reference Centers for SIDS.<br />
Sudden unexpected death in infants under 3 months <strong>of</strong> age <strong>and</strong> vaccination status – a case-control<br />
study. British Journal <strong>of</strong> Clinical Pharmacology 2001;51:271-6.<br />
74. Gobiowska M, Kardas-Sobantka D, Chlebna-Sokół D, Sabanty W. Hepatitis B vaccination in<br />
preterm infants. European Journal <strong>of</strong> Pediatrics 1999;158:293-7.<br />
75. Blondheim O, Bader D, Abend M, et al. Immunogenicity <strong>of</strong> hepatitis B vaccine in preterm infants.<br />
Archives <strong>of</strong> Disease in Childhood Fetal <strong>and</strong> Neonatal Edition 1998;79:F206-8.<br />
76. Munoz FM. Influenza virus infection in infancy <strong>and</strong> early childhood. Paediatric Respiratory<br />
Reviews 2003;4:99-104.<br />
77. Haller W, Buttery J, Laurie K, et al. Immune response to p<strong>and</strong>emic H1N1 2009 influenza A<br />
vaccination in pediatric liver transplant recipients. Liver Transplantation 2011;17:914-20.<br />
78. Cutolo M, Seriolo B, Pizzorni C, et al. Use <strong>of</strong> glucocorticoids <strong>and</strong> risk <strong>of</strong> infections. Autoimmunity<br />
Reviews 2008;8:153-5.<br />
79. American Academy <strong>of</strong> Pediatrics. Immunization in special clinical circumstances.<br />
Immunocompromised children. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red<br />
Book: 2009 report <strong>of</strong> the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL:<br />
American Academy <strong>of</strong> Pediatrics, 2009.<br />
80. <strong>Department</strong> <strong>of</strong> <strong>Health</strong> <strong>and</strong> Human Services, Centers for Disease Control <strong>and</strong> Prevention, National<br />
Immunization Program. Advisory Committee on Immunization Practices, June 29–30, 2006,<br />
Atlanta, Georgia. Record <strong>of</strong> the proceedings. 2006. Available at:<br />
http://www.cdc.gov/vaccines/acip/meetings/minutes-archive.html (accessed Nov 2012).<br />
81. Mitus A, Holloway A, Evans AE, Enders JF. Attenuated measles vaccine in children with acute<br />
leukemia. American Journal <strong>of</strong> Diseases <strong>of</strong> Children 1962;103:413-8.<br />
82. Monafo WJ, Haslam DB, Roberts RL, et al. Disseminated measles infection after vaccination in a<br />
child with a congenital immunodeficiency. Journal <strong>of</strong> Pediatrics 1994;124:273-6.<br />
83. Galea SA, Sweet A, Beninger P, et al. The safety pr<strong>of</strong>ile <strong>of</strong> varicella vaccine: a 10-year review.<br />
Journal <strong>of</strong> Infectious Diseases 2008;197 Suppl 2:S165-9.<br />
84. Hesseling AC, Marais BJ, Gie RP, et al. The risk <strong>of</strong> disseminated Bacille Calmette-Guerin (BCG)<br />
disease in HIV-infected children. Vaccine 2007;25:14-8.<br />
85. Kappagoda C, Shaw PJ, Burgess MA, Botham SJ, Cramer LD. Varicella vaccine in non-immune<br />
household contacts <strong>of</strong> children with cancer or leukaemia. Journal <strong>of</strong> Paediatrics <strong>and</strong> Child <strong>Health</strong><br />
1999;35:341-5.<br />
86. de Greeff SC, Mooi FR, Westerh<strong>of</strong> A, et al. Pertussis disease burden in the household: how to<br />
protect young infants. Clinical Infectious Diseases 2010;50:1339-45.<br />
87. Dylag AM, Shah SI. Administration <strong>of</strong> tetanus, diphtheria, <strong>and</strong> acellular pertussis vaccine to<br />
parents <strong>of</strong> high-risk infants in the neonatal intensive care unit. Pediatrics 2008;122:e550-5.<br />
88. Lehrnbecher T, Schubert R, Allwinn R, et al. Revaccination <strong>of</strong> children after completion <strong>of</strong><br />
st<strong>and</strong>ard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different<br />
schedules. British Journal <strong>of</strong> Haematology 2011;152:754-7.<br />
89. Hjuler T, Wohlfahrt J, Staum Kalt<strong>of</strong>t M, et al. Risks <strong>of</strong> invasive pneumococcal disease in children<br />
with underlying chronic diseases. Pediatrics 2008;122:e26-32.<br />
90. Siber GR, Chang I, Baker S, et al. Estimating the protective concentration <strong>of</strong> anti-pneumococcal<br />
capsular polysaccharide antibodies. Vaccine 2007;25:3816-26.<br />
91. Addiego JE, Jr., Ammann AJ, Schiffman G, et al. Response to pneumococcal polysaccharide<br />
vaccine in patients with untreated Hodgkin‘s disease. Children‘s Cancer Study Group Report. The<br />
Lancet 1980;2:450-3.<br />
92. Patel SR, Bate J, Borrow R, Heath PT. Serotype-specific pneumococcal antibody concentrations<br />
in children treated for acute leukaemia. Archives <strong>of</strong> Disease in Childhood 2012;97:46-8.
Change language